Magazine Article | October 2, 2023

Using AI To Find And Develop Safer Medicines

Source: Life Science Leader

By Ben Comer, Chief Editor, Life Science Leader

What if safer drugs for treating chronic conditions lie hidden in the foods, herbs, and traditional medicines human beings have consumed for millennia? And what if new technology could effectively screen and sort through some 100,000 molecules contained in those foods, herbs, and traditional medicines, digitize and decode them for drug-like properties, and match them with the biological pathways responsible for disease? That is the premise behind Montai Health, a seed company launched by Flagship Pioneering last December with a $50 million Series A investment. With chronic diseases, “most of the existing therapies are not safe for long-term use,” says Margo Georgiadis, cofounder and CEO at Montai Health. “We’ve always known that food is medicine, but we’ve never understood it at a molecular level.” Georgiadis and Flagship Pioneering are betting that scale capabilities in computation will make drug discovery more predictable and help unveil a new generation of what the company calls “anthromolecule” therapies.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader